Deals

Find out who’s buying, who’s selling and what is being sold. Get detailed information on the structures involved in secondaries deals, including LP portfolio sales, GP-led processes, spin-outs, restructurings and stapled deals.

GP-led secondaries begin to gain track record with returns beyond 2x – PJT

Traditional LPs contemplating GP-led focused funds have been intent on identifying examples of fully crystallised continuation funds in recent years.

PGGM runs large secondary on its private equity portfolio as LP sales dominate

Pricing for secondaries has improved to a net-asset-value level of around 90% for buyout funds.

Neuberger Berman steps up as lead on GenNx360 single-asset process for PAG

The single-asset deal is among a slew of mid-market transactions that are keeping secondaries buyers busy, despite a slowdown earlier in the year on the GP-led side.
Jun Qian, head of China private equity at Schroders Capital

Schroders taps 40% discounts on China’s RMB secondaries

A mismatch between the supply of potential deals and the number of institutional buyers has given Schroders significant 'bargaining power', says Jun Qian, the firm's head of China PE.
A chocolate pie against a purple background. The pie has been cut into 10 slices, with one being removed

TDR mulls strip sale on multiple vehicles

The buyout firm and owner of UK supermarket chain Asda has mandated Rede Partners to explore a process on its third and fourth flagship funds.
Handshake real estate deal

AlpInvest takes lead role in large Leonard Green multi-asset deal

The rationale for the deal is to provide liquidity to investors in older funds while still holding the assets.
college students

UC Regents runs $1.2bn LP sale of infra fund stakes

The sale is being run in steps, with the first round of about $500m recently closed.
Wellcome Trust medical research endowment DNA

Excellere runs two-asset GP-led on AIS Healthcare, LucidHealth

GP-led deal activity has slowed in the market downturn as buyers look for mostly high-quality assets and continue to seek diversity through LP portfolio sales.
iPad with medical data and stethoscopes

ICG emerges as buyer on New Mountain’s $1bn-plus continuation fund

New Mountain is running the single-asset process for medical data-focused Datavant, which it acquired through a merger with its portfolio company Ciox Health in 2021.
Asian scientist or doctors use microscopes to test for the coronavirus (COVID 19). Or a new flu virus to save human life In the lab Or hospital. Successful in researching the treatment of patients

Cinven seeks continuation fund deal for Dutch life sciences distributor

The firm had considered running a process on the same portfolio company at the end of last year, Secondaries Investor has learned.
si
si

Copyright PEI Media

Not for publication, email or dissemination